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ABSTRACT
￿
Rabbit antisera to highly purified synaptic vesicles from the electric organ of
Narcine brasiliensis, an electric ray, reveal a unique population of synaptic vesicle antigens in
addition to a population shared with other electric organ membranes. Synaptic vesicle antigens
were detected by binding successively rabbit antivesicle serum and radioactive goat anti-rabbit
serum. To remove antibodies directed against antigens common to synaptic vesicles and other
electric organ fractions, the antivesicle serum was extensively preadsorbed against an electric
organ membrane fraction that was essentially free of synaptic vesicles . The adsorbed serum
retained 40% of its ability to bind to synaptic vesicles, suggesting that about half of the
antigenic determinants are unique. Vesicle antigens were quantified with a radioimmunoassay
(RIA) that utilized precipitation of antibody-antigen complexes with Staphylococcus aureus
cells. By this assay, the vesicles, detected by their acetylcholine (ACh) content and the antigens
detected by the RIA, have the same buoyant density after isopycnic centrifugation of crude
membrane fractions on sucrose and glycerol density gradients. The ratio of ACh to antigenicity
was constant across the vesicle peaks and was close to that observed for vesicles purified to
homogeneity. Even though the vesicles make up only -0.5% of the material in the original
homogenate, the ratio of acetylcholine to vesicle antigenicity could still be measured and also
was indistinguishable from that of pure vesicles. We conclude that synaptic vesicles contain
unique antigenic determinants not present to any measurable extent in other fractions of the
electric organ. Consequently, it is possible to raise a synaptic vesicle-specific antiserum that
allows vesicles to be detected and quantified . These findings are consistent with earlier
immunohistochemical observations of specific antibody binding to motor nerve terminals.
Synaptic vesicles have been purified to homogeneity from the
electric organ of Narcine brasiliensis (3). They contain acetyl-
choline (ACh), ATP, and GTP. Their membrane has a high
concentration of cholesterol and conventional phospholipids
(5) and a small amount of protein contained in about eight
major polypeptide bands (16, 17). The absence of unique
enzyme markers in the synaptic vesicle membrane has pre-
vented the study ofthe biogenesis of the vesicle membrane and
its fate during and after exocytosis. To develop a vesicle-
specific marker, we have used immunological techniques to
recognize unique antigenic determinants on synaptic vesicles.
Antisera from rabbits immunized with pure synaptic vesicles
were found to bind selectively to motor nerve terminals of rat,
chick, and frog (12), which suggested that synaptic vesicles had
unique antigenic determinants. Here we show biochemically
that the antigenic components of vesicles can be divided into
specific determinants associated exclusively with vesicles and
shared determinants foundon other membrane fractions. After
adsorption to remove antibodies to the shared determinants,
the serum becomes specific for unique synaptic vesicle antigens.
In addition, the serum can be used to quantify the presence of
vesicle membranes in crude homogenates. Presumably, because
of the high purity of the vesicles used as the immunogen and
the biochemical simplicity of the vesicles, we have succeeded
in generating an organelle-specific antiserum, which should be
useful in studies of vesicle biogenesis and turnover and of
synaptic development. The serum has already proved useful in
defining a subclass of mammalian nerve terminals, unrecog-
nized by other means (8). In addition, the serum has provided
immunocytochemical evidence for the transfer of vesicle anti-
gens to the plasma membrane of the nerve terminal during
transmitter release.'
Other studies have used antibodies to organelle-specific pro-
' von Wedel, R. J., S. S. Carlson, and R. B. Kelly. Manuscript in
preparation.
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mine i(i-hydroxylase (4) and to clathrin (1) are markers for
chromaffin granules and coated vesicles, respectively. In this
case, a serum was raised to a secretory granule not known in
advance to contain a specific antigen. We have also been able
to use the specific antigens to develop a quantitative assay for
the organelle. A preliminary account of this work has already
been published (2).
MATERIALS AND METHODS
Materials
The IgG fraction ofgoat anti-rabbit IgG (heavyand light chains) wasobtained
from Cappel Laboratories, Downingtown, Pa. 'z`'I(sodium salt) and [y12P]ATP
(3,000 Ci/mmol) were provided by New England Nuclear, Boston, Mass.
Reagents required to synthesize "''I-diazotized iodosulfanilicacid (I'21]-DISA)
were purchased from New England Nuclear (NY-121). Particle Data Laborato-
ries Ltd. Elmhurst, III. supplied the Nonidet P40 (NP-40). Amido schwarz
(Naphthol Blue Black) was purchased from Eastman Organic Chemicals Div.,
Eastman Kodak Co., Rochester, N. Y. Bovine serum albumin (A-4378) (BSA),
HEPES, acetylcholineesterase (type 5), choline kinase, ACh, sodium tetraphen-
ylboron, ATP, and sodium azide were obtained from Sigma Chemical Co., St.
Louis, Mo. Bordetalla pertussis vaccine was purchased from Eli Lilly and Co.,
Indianapolis, Ind. Difco Laboratories, Detroit. Michigan provided Freund's
adjuvant (complete and incomplete) and dried tubercle bacilli. Fetal calf serum
was obtained from Grand Island Biological Co., Grand Island, N. Y. The 96-
hole polyvinyl flexible microtiter U-plates were purchased from Dynatech Lab-
oratories, Inc., Alexandria, Va. Whatman Inc., Clifton, N. J. supplied the SB-2
filter paper for the acetylcholine assay. The Staphlyococcus aureus cells (SAC)
were a generous gift of Zach Hall and Crispin Weinberg, Dept of Physiology,
University of California, San Francisco.
Assays
Protein was determined by amido schwarz staining (l3). ACh was measured
by the method of Goldberg and McCaman (7), with a minor modification (3).
Ouchterlony immunodiffusion tests were done in detergents according to the
methods of Yen et al. (18) or Martonosi and Fortier (11).
"'I-Labeling of Synaptic Vesicle Antigens
"''I-synaptic vesicle antigens were prepared by reaction of [`I]DISA with
synaptic vesicles in NP-40 (16). An aliquot of 200pCi of "'I-p-amino,m-iodosul-
fanilic acid (> 1,000 Ci/mmol), wasconverted to DISA according tothetechnical
information supplied by NewEngland Nuclear. Synaptic vesicles (50fig protein)
in 0.4 MNaCl, 10 mM Na phosphate, pH 7.0, and 0.5% NP-40 were added to the
DISA to a final volume of 360 pl and allowed to react overnight at 4°C. To
quench the reaction, neutralized ethanolamine (final concentration, 3 mM)was
added. Approximately 4x 10'' TCA-precipitable cpm were obtained per micro-
gram of vesicle protein. The ['s",I]DISA-labeled synaptic vesicle antigens were
used without further purification.
Immunization of Rabbits
New Zealand White rabbits were sensitized with 0.5 ml of crude Bordetalla
pertussis vaccine intradermally 2 d before injection. Purified whole synaptic
vesicles (3) (1001+g protein) and 50 pg of dried tubercle bacilli in 2 ml of 0.4 M
NaCl, 10 mM HEPES, pH 7.0, were emulsified with 2 ml of Freund's complete
adjuvant and injected intradermally at several sites in the back of each rabbit.
After I mo, each rabbit was boosted with whole synaptic vesicles (100 jig protein
in 2 ml of0.4 M NaCl, 10 mM HEPES, pH 7.0, emulsified with 2 ml Freund's
incomplete adjuvant) intradermally. Each rabbit was bled 5 d later. Theschedule
of boosting and bleeding was repeated three times al 3-wk intervals. All rabbits
immunized with vesicles responded.
Solid-phase Assay of Antibody Binding
The procedure is a modification ofpublished procedures (10, 14). 50pl ofthe
antigen (0-6pg/ml protein) in phosphate-buffered saline (PBS)-sucrose dilution
buffer (0.15 M NaCl, 0.5 M sucrose, 20 mM sodium phosphate, pH 7.5, 0.02%
sodium azide) were adsorbed to a plastic microtiter U-plate overnight at 4°C.
The wells were washed three times with 1% fetal calf serum in PBS-sucrose. 50
lal ofthe appropriate dilution ofantisynaptic vesicle antiserum (diluted in 1% BSA
in PBS-sucrose) was added to the microtiter wells. After overnight incubation at
4°C, the wells were washed three times with 1% fetal calfserum in PBS-sucrose.
25 ld (10,000-30,000 cpm) ofgoat anti-rabbit ["''I]IgG iodinated by the chlora-
mine T method (6) to ^-1.5 x 10" cpm/mg were added to the wells. The goat
anti-rabbit serum was dissolved in PBS-sucrose, 1% BSA. The wells were incu-
bated overnight at 4°C, washed with I% fetal calf serum in PBS-sucrose, blotted
dry, and counted in a gamma counter.
Staphylococcus aureus Radioimmunoassay (RIA)
of Antigen Concentration
In this assay, detergent solubilized "`I-labeled synaptic vesicle antigens com-
pete with unlabeled vesicle antigens for bindingtoantisynaptic vesicle antibodies.
The ["I]DISA synaptic vesicle antigens (2-4 x 10° TCA-precipitable cpm), 0.1
pl of antiserum, and the sample to be assayed were incubated in 250 pl of RIA
buffer (0.4 M NaCl, 10 mM HEPES, pH 7.5, 0.5% NP-40, 0.02% sodium azide,
0.01% BSA) at 4°C for 15 min. This optimum antiserum concentration was
determined by comparing the radioactivity bound in the absence and presenceof
excess cold antigen at a series of antiserum dilutions from 100-fold to 250,000-
fold. Adsorbed and unadsorbed sera gave equivalentresults in this assay. Antigen-
antiserum complexes were precipitated by adding 25 pl of SAC, 100 ill of RIA
buffer, and then incubating for a further 15 min at 4°C. SAC was always in
excess with SAC:antisera ratios ofat least 25:1 (vol/vol). The complexes ofSAC,
antigen and antibody were separated from unbound material by centrifugation
through a pad of PBS-sucrose containing 0.5% NP-40 and 0.1% BSA for 6min
in a Brinkman centrifuge Model 5412 (Brinkmann Instruments, Inc., Westbury,
N. Y.). The pellet was counted. 64% of the '1''I-labeled, TCA-precipitable
radioactivity could be precipitated by the presence ofexcess antivesicle antibody
and SAC. The assay was able to measure reproducibly 0.05-I.0 lag of synaptic
vesicle protein (Fig. 1). Because the assay is relatively insensitive to the presence
of other membranes, it could be used to quantify vesicle concentration in crude
homogenates of electric organ. Although nonproteinaceous material could be
antigenic, the measured vesicle concentration is expressed in terms of protein
concentration. To distinguish vesicle protein measured by RIA from direct
determinations the term "RIA vesicle protein" is used.
SAC (Cowan I strain) were prepared according to Kessler (9) and stored at
-20°C. Just before use the SAC were resuspended in RIA buffer without BSA
and incubated at 4°C for 15 min. The cells were then spun down (I2,000g, 10
min) and resuspended in RIA buffer (10% wt/vol).
Adsorption of Antisera
To adsorb the antisera, antisera and membranes were mixed and diluted with
0.4 M NaCl, 1% BSA, 10 mM HEPES, pH 7.5, to 250-500 pl. After overnight
incubation at 4°C, the incubation mixture was diluted with 1.5 vol of the same
buffer and centrifuged at 80,000 gfor 5 h to pellet the membranes. The supernate
was saved.
Ifmembraneswere to be sonicated, a 0.5-1 ml sample (100-200itg/ml protein)
in a Brinkman centrifuge tube was held against the tip of a sonicator probe
(Model WIGS, Heat Systems-Ultrasonics, Inc., Plainview, N.Y.). The tip and
tube were in an ice bath. 10-s sonication periods were used, separated by 15-s
intervals, to give 2 minofsonication. These conditions release all bound ATP.`
NP-40 Detergent Extractions
A2.2 g(wet weight) sample of 12,000 gpellet, homogenized with 2.72 ml of
0.4 M NaCl, 10 mM HEPES, 5% NP-40.0.02% azide, pH 7.5, by 10 strokes ofa
Teflon-glass homogenizer, was spun for 20 min at 12,800 g, the supernate taken,
and the resulting pellet discarded. This supemate contained at least 77% of the
total extractable RIA vesicle protein from the 12,000 g pellet.
To extract the sucrose gradient pellet, 250 mg (wet weight) was mixed with
850 pl of RIA buffer and homogenized in a ground glass homogenizer. The
homogenate was then centrifuged at 12,800 g for 10 min, the supernate saved,
and the pellet discarded.
RESULTS
Characterization of Rabbit Antisynaptic
Vesicle Serum
When injected into rabbits, purified synaptic vesicles yielded
an antiserum that gave precipitin lines against the vesicles on
Deutsch, J. W. Unpublished observations.
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FIGURE 1 A standard curve for the RIA. The [1261]DISA synaptic
vesicle antigen precipitated by antiserum and S. aureus is plotted
against the amount of unlabeled synaptic vesicle protein added to
the reaction mixture. Thezero control (no unlabeled vesicle antigen
added) is shown by the dotted line.
Ouchterlony plates containing detergent. A more quantitative
and sensitive assayforthepresence ofantibodies wasthesolid-
phase binding assay in which the antigenwas first immobilized
on plastic wells of a microtiter plate. Rabbit antibodies that
bind to the immobilized antigen could be detected indirectly
using "'I-labeled goat anti-rabbit antibodies (1251-GAR). At
low antigen concentrations the binding of '251-GAR increased
linearly with the concentration of purified synaptic vesicles
boundto plastic wells. In a typical experiment, theinitialslope
when antigenwaslimiting was8.2 x 105 cpm/tLgvesicle protein
in the well. The results are expressed per microgram vesicle
protein, even though nonproteinaceous material may be anti-
genic.
Theextent to whichsynaptic vesicle antigens are shared with
other electric organ membranes was determined using mem-
brane fractions essentially free of synaptic vesicles. An espe-
cially convenient membrane preparation forthestudyofshared
antigens is the excluded material, so called because after per-
meation chromatography of the partially purified sucrose gra-
dientfraction (step four ofthevesicle purification, reference 3)
on Controlled Pore glass bead columns (Electro-nucleonics,
Inc., Fairfield, N. J.) this material is obtained in the void
volume. On this column, pure synaptic vesicles are included,
and larger sized membranous contaminants are eluted in the
excluded fraction (3). The excluded material has a different
protein (15, 16) and lipid composition' than the synaptic
vesicles, and has a higher protein to lipidratio (15). Because it
contains only trace amountsof the proteins that copurify with
vesicles (16), it is useful as a "vesicle-free" membrane prepa-
ration, especially because it is the most likely contaminant of
vesicle preparations.
To detect shared antigens, binding of the antivesicle serum
to the excluded material membranes was compared with the
binding of the antivesicle serum to synaptic vesicles. Whereas
synaptic vesicles bound 8.2 x 105 cpm/,ug protein in the well,
the corresponding value for excluded material was 2.4 x 105
cpm/lLg proteinin thewell. Synaptic vesicles appear, therefore,
to share antigens with other electric organ membranes.
Adsorption ofthe serumwith excluded material membranes
' Deutsch, J. W., and R. B. Kelly. Manuscript in preparation.
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did not remove all the antibody activity. A population of
antibodies that cannot be adsorbed by excluded material was
demonstrated by adsorption of the antiserum with different
amounts of electric organ membranes. A plateau was reached
when 40% remained of the antiserum that bound to synaptic
vesicles (Fig. 3, curve A). The adsorbed sera did not bind
detectably to excluded material. The residual 40% of the anti-
bodies couldbe removed by adsorption with sonicated synaptic
vesicles (Fig. 3, curve C). These data validate the earlier
assumption that the membranes of the excluded material used
in the adsorption assay are relatively uncontaminated with
synaptic vesicles.
In other experiments, we have used the 12,000 g pellet
fraction from the vesicle purification (3) to adsorb antibodies
directed at shared antigens. Because synaptic vesicles make up
<1% of the material in this fraction, as we shall show later,
such an adsorption also enriches the serum in antibodies to
specific vesicle determinants. Adsorption with the 12,000 g
pellet gave data similar to those shown in Fig. 2, and identical
results during immunocytochemical studies.
When the antiserum was extensively adsorbed with intact
synaptic vesicles (Fig. 2B) instead of sonicated ones (Fig. 2C)
80% of the antibodies were removed. The remaining 20%
presumably are directed against antigens inaccessible in intact
vesicles and revealed by vesicle lysis. These inaccessible anti-
gens must also be revealed when the vesicles adhere to the
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FIGURE 2 Selective adsorptions of antisynaptic vesicle antiserum.
Immunological reactivity of each adsorbed antiserum was measured
in the solid-phase assay using limiting concentrations of synaptic
vesicles and the results plotted on the ordinate (counts per minute
antibody bound per microgram synaptic vesicle protein in the well) .
The amount of membrane protein (jug) used to adsorb a given
volume (ul) of antiserum is plotted on the abscissa as the ratio of
micrograms per microliter. Curve A (A) is antiserum adsorbed with
sonicated electric organ membranes excluded during glass bead
chromatography; curve B (N) is antiserum adsorbed with intact
synaptic vesicles; curve C(") is antiserum adsorbed with sonicated
synaptic vesicles.plastic during the solid-phase assay. Indeed, antibody binding
was identical in this assay whether intact or sonicated vesicles
were used.
These experiments showed that unadsorbed antivesicle an-
tiserum recognized antigens shared by synaptic vesicles and
excluded material, whereas adsorbed antiserum recognized a
unique set of antigens not present in excluded material. To
show that these antigens are truly unique to the synaptic
vesicles, it was necessary to show that no other subcellular
component of the electric organ contained them.
Vesicle Antigens are Restricted to ACh-
containing Membranes
To demonstrate that the antigens detected by our sera are
restricted to synaptic vesicles, we showed that the antigens
copurify with vesicles. Isopycnic centrifugation of the 100,000-
g membrane fraction (3) on a glycerol density gradient gave
the results shown in Fig. 3. Such gradients have been shown to
separate vesicular membranes on the basis of physical proper-
ties different from those used in separation on sucrose density
gradients (15). On a glycerol density gradient the protein in the
100,000-g pellet separated into two broad peaks (Fig. 3). The
synaptic vesicles, detected by their ACh content, came to
equilibrium at -1.120 g/cm'', in agreement with earlier mea-
surements with pure vesicles (3). Vesicle antigens were detected
by the S. aureus RIA described in Materials and Methods. This
assay has two advantages over the well assay. It can be used
when the amount of vesicle antigen is only a small fraction of
the total material present, and it gives a reliable measure of
antigen concentration, which the well assay does not. Using
this assay, we found the vesicle antigenicity to be restricted to
the synaptic vesicle fraction (Fig. 3). At the vesicle peak, the
RIA vesicle protein was -8% of the total protein and the
specific activity was 1,900 ± 800 pmol ACh/lig RIA vesicle
protein. The specific activity was constant across the vesicle
peak and was close to that obtained for the initial 100,000 g
membrane fraction (Table I). If the antiserum had bound to
material in this fraction other than synaptic vesicles, an increase
in specific activity would be expected during fractionation of
the membranes. These data are, therefore, consistent with the
restriction of antiserum binding sites to vesicles.
TABLE I
The RIA assay only detects vesicle components that label
with [125I]DISA. To detect other potential antigens, equal vol-
umes of the gradient fractions (Fig. 3) were adsorbed to the
plastic microtiter plates and antibody binding measured using
the [125I]GAR procedure described in Materials and Methods.
A peak ofbinding was observed coincident with the ACh peak
and the peak of RIA vesicle protein. The ratio of radioactivity
to RIA vesicle protein was constant from fraction 11 to fraction
20 (1 .25 ± 0.15 x 105 cpm/gg RIA vesicle protein).
The 100,000-g membrane fraction was also analyzed by
sucrose density gradient centrifugation (Fig. 4). The only gra-
dient fractions that were antigenic, as detected by the S. aureus
assay, also contained ACh and ATP. The ratio of ACh to RIA
vesicle protein was constant across the peak. The average
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FIGURE 3 Coincidence of synaptic vesicle antigenicity and ACh-
containing vesicles in a crude synaptic vesicle preparation fraction-
ated by isopycnic centrifugation on a glycerol density gradient. A
crude synaptic vesicle preparation (100,000-g pellet) was made from
19 g of Narcine electric organ (3) . The resuspended pellet (5 ml of
0.4 M NaCl, 10 mM HEPES, pH 7.0) was layered on a 21-m1, 15-70%
glycerol gradient (0.4 M NaCl, 10 mM HEPES, pH 7.0). The glycerol
gradient wascentrifuged for 18 h, 4°C, at 100,000-g in a Beckman 30
rotor (Beckman Instruments, Inc., Fullerton, Calif.). 25 (1.08-ml)
fractions were collected. Total protein ("), acetylcholine (A), density
(. ), and the synaptic vesicle antigenicity measured by the S.
aureus RIA (/) are shown . The recovery of RIA vesicle protein in
the peak fraction varied from 70 to 100% in fractionations on glycerol
density gradients.
* SD are given. Parentheses refer to the number of measurements made.
$ The sum of the 12,000 g supernate and pellet are taken as 100%.
§Wg RIA protein per gram of pellet.
~~ Based on the concentration of protein in an NP40 extract; see Materials and Methods.
Data on RIA vesicle protein and ACh was taken in this case from separate preparations. Thus, the SD includes the variation between preparations and not just
the variation in the measurements.
** No SD are given because these are the average of the values across the peak.
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Sample
RIA vesicle protein
% of total
Concentration* protein
covery
of RIA
vesicle
protein$
ACh
Concentration*
% Recov-
eryf
ACh/RIA vesicle
protein
PgIml nmol/ml pmol/iag
12,000 g Supernate 14 t 4 (14) 0.64 54 39 ± 7 (4) 65 2,800 t 960
12,000 g Pellet 100t 5§ (13) 0.311 46 180 t30 (4) 36 1,800 3= 400
100,000 g Supernate 1 .5 ± 0.2 (12) 0.03 5.5 <0.14 <U2 <94
100,000 g Pellet resuspendedl 88 t 7 (26) 3.4 43 210 t 100 (22) 44 2,400 ± 1,200
Glycerol gradient peak 54 (22)** 6.6 54 100 (20)** 41 1,900 t 770
Sucrose gradient peak 27 (38)** 17 14 73 (18)** 17 2,700 t 420
Sucrose gradient pellet 315 t 64§ (14) 14 66 t 16 (8) 1 .2 210 t 38specific activity, 2,800 nmol ACh/mg RIA vesicle protein was
again close to that of the initial 100,000-g pellet (Table I).
In this experiment, 33% of the RIA vesicle protein applied
to the gradient was recovered in the vesicle peak and 33% was
recovered in thepellet. Because the ratioofACh to RIAvesicle
protein of the pellet fraction was lower than the starting
material (Table I), we suspect that the pellet contained lysed
synaptic vesicles, and perhaps also trapped vesicles.
We did not subject the vesicle peak in this experiment to
further purification. In several experiments, however, in which
only ATP was measured, the ratio of ATP to RIA vesicle
protein of the sucrose and glycerol density gradient peaks was
found to be insignificantly different from that of vesicles
purified to homogeneity by Controlled Pore glass chromatog-
raphy, even though the ratio of ATP to total protein changed
markedly (Table II). By definition, the protein in the purified
synaptic vesicles is 100% RIA vesicle protein.
Detection of Vesicle Antigenicity in Impure
Fractions
The above experiments implied that in the 100,000-g mem-
FRACTION NUMBER
FICURE 4 Coincidence of synaptic vesicle antigenicity and ATP-
containing synaptic vesicles in a crude synaptic vesicle preparation
fractionated by equilibrium flotation centrifugation on a sucrose
density gradient. A crude synaptic vesicle preparation (100,000-g
pellet) was made from 32 g of Narcine electric organ (3) . This
material was then fractionated by isopycnic centrifugation on a
sucrose density gradient as previously described (3), with the slight
modification that a 0.65 M sucrose, 0.075 M NaCl solution was
substituted for the 0.5 M sucrose, 0.15 M NaCl solution in the
layered sucrose gradient. The gradient (27-ml) wascollected in 1-ml
fractions. Total protein ("), ATP (O), density (. " ), and the synaptic
vesicle antigenicity measured by the S. aureus RIA (") are shown in
the figure. It has previously been demonstrated that synaptic vesicles
that contain ACh and ATP float to a density of 1 .059 g/cm3 under
these centrifugation conditions (15) . A pellet that contains acetyl-
choline and that demonstrates antigenicity results from this sucrose
gradient fractionation. These ACh and antigenicity concentrations
are not presented on the figure, but are shown in Table I.
TABLE II
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Comparison of ATP/ RIA Vesicle Protein Ratios with ATP-Spe-
cific Activities for Purified and Partially Purified Vesicles
ATP/RIA vesicle
￿
ATP/total pro-
* The numbers in parentheses refer to the number of separate preparations
used to calculate the means ± SD given.
brane fraction the bulk of the antigens recognized by the
antiserum are restricted to synaptic vesicles. This fraction was
obtained from a 12,000-g supernate after the conventional
vesicle purification procedure (3). We have also measured the
amount of vesicle antigen in the 12,000-g supernate and pellet
and in the 100,000-g supernate (Table 1) to determine whether
a significant antigen-containing fraction was being lost in the
earlysteps. Only -10%ofthe RIAvesicle protein in the 12,000-
g supernate is lost in the 100,000-g supernate. Centrifugation
ofthe initial homogenate at 12,000 g, however, sedimentsabout
half the RIA protein into the pellet. This could either mean
that about half the antigens detected by the antivesicle antise-
rum are in large membrane fragments, sedimentable at 12,000
gor that about halfthesynaptic vesicles are trapped. The ACh
measurements favor the latter conclusion. Approximately 50%
ofthe ACh, whichwas presumably in avesicularform because
no esterase inhibitors were included (17), was also found in the
12,000-g pellet. Indeed, the specific activity of all thefractions,
with the exception of the 100,000-gsupernate, was remarkably
constant,even though the fraction of the totalproteinestimated
to be RIA vesicle protein varied from 0.3% to 17% (Table 1).
These results show that most of the material in the 12,000-g
supernate that is recognized by the antiserum is associated with
synaptic vesicles. The material lost in the 12,000-g pellet is not
well described but could be attributable to trapped vesicles.
DISCUSSION
Immunohistochemical studies at the light microscope level
show that the antiserum raised to electric organ synaptic vesi-
cles described here binds specifically to motor nerve terminals.
Adsorption of the serum with excluded material membranes
reduced background binding without detectably changing
nerve terminal binding (12). In agreement with these findings,
antigenic sites in synaptic vesicle preparations can be divided
biochemically into those unique to synaptic vesicles and those
shared with electric organ membranes by measuring the bind-
ingof adsorbed andunadsorbed serum. It is notknownwhether
the shared antigenic determinants correspond to membrane
components common to synaptic vesicles and other electric
organ fractions or whether they are on membranes that con-
taminate thesynaptic vesicle preparation. Theunique antigenic
determinants on the synaptic vesicles can further be subdivided
into antigens exposed on the intact vesicle and those that are
only exposed upon sonication. Some or all of those exposed
after sonication may be antigens on the inner surface of the
vesicle membrane.
Synaptic vesicle antigens were detected by two immunolog-
ical techniques, the solid-phase binding assay andthe S. aureus
RIA. The solid-phase assay measures the antigenic material
that binds to plastic. When mixtures of membranes are used,
the results are influenced by competitive binding and selective
adsorption. Because excess antiserum is used, all antigens
should be detectable. The S. aureus RIAdetects only detergent-
solubilized antigens that can be labeled with [FZ5I]DISA. Based
on the known reactivity of diazo- compounds, both proteins
and aminolipids might be labeled and detected in the assay if
they retain their antigenicity after labeling and detergent sol-
ubilization. In contrast to the solid-phase assay, the RIA is
performed in limiting antibody concentrations so that antigens
that are highly antigenic are more readily detected. Fortu-
nately, although thetwoassays mightdetect different antigenic
populations, both those populations copurify with ACh-con-
taining vesicles upon isopycnic centrifugation.
Sample protei n
pmol1m
tein
pmolItrg
Sucrose gradient peak 1,400 ± 440 (3)* 220 ± 160 (1)
Glycerol gradient peak 990± 330 (2) 73 ± 46 (1)
Purified synaptic vesicles 2,300 ± 1,300 (8) 2,300 ± 1,300 (8)We can use the presence of unique antigens on synaptic
vesicles to validate the vesicle purification scheme previously
published (3). The specific activity of the synaptic vesicles in
crude fractions was constant at ^-2,000 pmol ACh/lig RIA
vesicle protein, which is in the rangeofspecific activities found
forpurified vesicles and comparable to that found for ourbest
vesicle preparations (3). Most of the ACh in these crude
fractions are, therefore, probably associated with structures
that are similar to the purified synaptic vesicles, at least in
antigen composition. This is an important conclusion because
the original purification of synaptic vesicles to homogeneity
was achieved with a final yieldof only 3% of the ACh present
in the electric organ. The second observation, which is in
keeping with the purification scheme, is that theconcentration
of RIA vesicle protein in the 12,000-g supernate is only ^-0.6%
ofthe totalproteinin this fraction (Table I), This explains why
>I00-fold purification of the 12,000-g supernate was necessary
to achieve purification to homogeneity (3).
These biochemical experiments put limits on the level of
specific synaptic vesicle antigens present in nonvesicle mem-
branes of the 12,000-g supernate. If such a component con-
tained as little as one-fourth of the specific antigens present in
synaptic vesicles, it should have been detectable by an increase
in specific activity on purification (Table I). It is of special
interest to know whether the specific antigens in vesicles are
also present in the presynaptic plasma membrane. Unfortu-
nately, because this membrane might be in the 12,000-g pellet,
we canonly conclude that there is notmore RIA vesicle protein
in thepresynaptic plasma membrane of the electric organthan
there is in the vesicles themselves.
We conclude that it is possible, at least in the case of the
synaptic vesicle, to develop an organelle-specific antiserum.
With such a serum, RIA analogous to those used to quantify
proteins andothersimple antigens canbe developed, butwhich
in this case allow us to measure organelle concentration. For-
tunately, the antiserum raised to elasmobranch synaptic vesi-
cles cross-reacts with elements of the mammalian nervous
system in a way consistent with recognition of mammalian
synaptic vesicles (8, 12). The antiserum may, therefore, be of
value in following vesicle biogenesis and turnover in both the
electric organ and the mammalian nervous system.
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